Shares of Sudharshan Pharma Industries gained on Friday i.e. on April 25 2025 on the back of positive quarterly results. The gain comes even as the stock market gave up early gains to trade lower. The scrip started the session at Rs 27.80 also it upper circuit as against the previous close of Rs 27.26. The 52-week high of the stock is Rs 53.50 and the 52-week low is Rs 5.82. The scrip has given a multibagger return of 252 per cent in one year and 275 per cent in two years. However it has corrected 39.31 per cent so far this year. Quarter Results The surge in the share price comes as the company has announced its quarterly results for the fourth quarter of the financial year 2024-25. According to information shared with the exchanges the companys standalone revenue grew by 20 per cent YoY. It has grown from Rs 232 crores in Q4FY24 to Rs 277 crores in Q4FY25. Also there is an increase of 21.5 per cent QoQ revenue. (From Rs 228 crores in Q3FY25 to Rs 277 crores in Q4FY25.) The Pharma companys net Profit grew by 50 per cent YoY from Rs 6.60 crores in Q4FY24 to Rs 10 crores in Q4FY25 but this includes an exponential income worth 1.65 crores obtained from the sale of an extended producer responsibility certificate. Meanwhile Asian markets South Koreas Kospi index Tokyos Nikkei 225 Shanghai SSE Composite and Hong Kongs Hang Seng were trading in the positive territory. US markets ended significantly higher on Thursday.Nasdaq Composite jumped 2.74 per cent S&P 500 surged 2.03 per cent and Dow Jones Industrial Average climbed 1.23 per cent. Foreign Institutional Investors (FIIs) bought equities worth Rs 8250.53 crore on Thursday according to exchange data. Global oil benchmark Brent crude climbed 0.53 per cent to USD 66.90 a barrel.